162 related articles for article (PubMed ID: 7517998)
1. Vascularization and microvascular permeability in solid versus cell-suspension embryonic neural grafts.
Leigh K; Elisevich K; Rogers KA
J Neurosurg; 1994 Aug; 81(2):272-83. PubMed ID: 7517998
[TBL] [Abstract][Full Text] [Related]
2. Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological, and immunological considerations.
Broadwell RD; Baker BJ; Ebert PS; Hickey WF
Microsc Res Tech; 1994 Apr; 27(6):471-94. PubMed ID: 8012052
[TBL] [Abstract][Full Text] [Related]
3. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology.
Nikkhah G; Olsson M; Eberhard J; Bentlage C; Cunningham MG; Björklund A
Neuroscience; 1994 Nov; 63(1):57-72. PubMed ID: 7898661
[TBL] [Abstract][Full Text] [Related]
4. Functional improvement with low-dose dopaminergic grafts in hemiparkinsonian rats.
Bartlett LE; Sadi D; Lewington M; Mendez I
Neurosurgery; 2004 Aug; 55(2):405-12; discussion 412-5. PubMed ID: 15271249
[TBL] [Abstract][Full Text] [Related]
5. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior.
Heim RC; Willingham G; Freed WJ
Exp Neurol; 1993 Jul; 122(1):5-15. PubMed ID: 8101821
[TBL] [Abstract][Full Text] [Related]
6. Expression of platelet-derived growth factor in and around intrastriatal embryonic mesencephalic grafts.
Smits A; Odin P; Duan WM; Brundin P; Widner H; Heldin CH; Lindvall O; Funa K
Cell Transplant; 1993; 2(2):151-62. PubMed ID: 7908247
[TBL] [Abstract][Full Text] [Related]
7. Development of intracerebral dopaminergic grafts: a combined immunohistochemical and autoradiographic study of its time course and environmental influences.
Abrous N; Guy J; Vigny A; Calas A; Le Moal M; Herman JP
J Comp Neurol; 1988 Jul; 273(1):26-41. PubMed ID: 3145292
[TBL] [Abstract][Full Text] [Related]
8. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
Nishino H; Hida H; Takei N; Kumazaki M; Nakajima K; Baba H
Exp Neurol; 2000 Jul; 164(1):209-14. PubMed ID: 10877931
[TBL] [Abstract][Full Text] [Related]
9. Permeability to blood-borne protein and 3HGABA in CNS tissue grafts. I. Intraventricular grafts.
Rosenstein JM
J Comp Neurol; 1991 Mar; 305(4):676-90. PubMed ID: 2045541
[TBL] [Abstract][Full Text] [Related]
10. Permeability of the blood-brain barrier to protein and [3H]GABA in intraparenchymal fetal CNS tissue grafts.
Rosenstein JM
Exp Neurol; 1996 Nov; 142(1):66-79. PubMed ID: 8912899
[TBL] [Abstract][Full Text] [Related]
11. Allografts of CNS tissue possess a blood-brain barrier. II. Angiogenesis in solid tissue and cell suspension grafts.
Broadwell RD; Charlton HM; Ebert PS; Hickey WF; Shirazi Y; Villegas J; Wolf AL
Exp Neurol; 1991 Apr; 112(1):1-28. PubMed ID: 2013306
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease.
Mendez I; Baker KA; Hong M
Brain Res Brain Res Rev; 2000 Apr; 32(1):328-39. PubMed ID: 10751681
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study.
Mendez I; Elisevich K; Flumerfelt B
J Comp Neurol; 1991 Jun; 308(1):66-78. PubMed ID: 1714923
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
Krobert K; Lopez-Colberg I; Cunningham LA
Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
[TBL] [Abstract][Full Text] [Related]
15. Temporo-spatial expression of bFGF and TGFbeta2 in embryonic dopaminergic grafts in a rat model of Parkinson's disease.
Sommer C; Sabel M; Oertel WH; Kiessling M; Sautter J
Brain Res Mol Brain Res; 1999 May; 69(1):53-61. PubMed ID: 10350637
[TBL] [Abstract][Full Text] [Related]
16. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
[TBL] [Abstract][Full Text] [Related]
17. Cellular distribution of the NMDA receptor subunit NMDAR1 in fetal ventral mesencephalon transplants in the dopamine-depleted striatum of a rat.
Todaka K; Ishida Y; Hashiguchi H; Nishimori T; Mitsuyama Y
Exp Neurol; 1999 Dec; 160(2):394-401. PubMed ID: 10619556
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis and the blood-brain barrier in intracerebral solid and cell suspension grafts.
Akalan N; Grady MS
Surg Neurol; 1994 Dec; 42(6):517-22. PubMed ID: 7529946
[TBL] [Abstract][Full Text] [Related]
19. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
Törnqvist N; Björklund L; Strömberg I
Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
[TBL] [Abstract][Full Text] [Related]
20. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
Yurek DM
Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
